← Today's headlines

14 sources checked · Left, Center, and Right included · 52m ago

Different Spin

FDA approves first m RNA flu vaccine for adults 50+

Fast Company and The Gateway Pundit describe the same event in different terms.

1 Left11 Center2 Right
Same story. Different framing. Left, center, and right outlets are covering the same event. Here’s how each side worded it.

DIFFERENT SPIN

HOW EACH SIDE WORDED IT

Left-leaningCenter-leftThis new kind of flu shot by Moderna has just been approved by the FDAFast CompanyMostly Factual
Right-leaningCenter-rightPa. experts welcome FDA approval of Moderna’s m RNA flu vaccinePittsburgh Tribune ReviewMostly Factual
Center baseline · WBIR10 (Tegna, Knoxville)HighFDA approves first m RNA flu vaccine for adults 50+

As of August 6, 2026 at 4:17 PM, this is how Optics News reads the wording differences in this story.

What happened The shot, named m Flusiva, is intended for adults age 50 or older.
The headline split The left frames it as "This new kind of flu shot by Moderna has just been approved by the FDA". The right frames it as "Pa. experts welcome FDA approval of Moderna’s m RNA flu vaccine".
Match confidence High confidence. 14 sources checked, Left/Center/Right all represented. Best read as a clear framing signal — not a fact-check.
Same-event confidenceHigh

14 sources across Left, Center, and Right all describe the same event.

Framing confidenceStrong

81/99 — headlines create a clearly different first impression.

WHAT EACH SIDE EMPHASIZED

Left / center-leftThis new kind of flu shot by Moderna has just been approved by the FDA

Fast Company · Center-left · News report

CenterFDA approves first m RNA flu vaccine for adults 50+

WBIR10 (Tegna, Knoxville) · Center · News report

Right / center-rightPa. experts welcome FDA approval of Moderna’s m RNA flu vaccine

Pittsburgh Tribune Review · Center-right · News report

SEE THE HEADLINES

CenterHigh
WBIR10 (Tegna, Knoxville)News report · Aug 6, 3:13 PM

FDA approves first m RNA flu vaccine for adults 50+

The shot, named m Flusiva, is intended for adults age 50 or older.

Open source
Center-rightMostly Factual
Pittsburgh Tribune ReviewNews report · Aug 6, 4:17 PM

Pa. experts welcome FDA approval of Moderna’s m RNA flu vaccine

Despite an uptick in vaccine skepticism among Americans, Pennsylvania doctors lauded the Food and Drug Administration’s approval Wednesday of the first m RNA flu vaccine.

Open source
CenterHigh
Honolulu Star-AdvertiserNews report · Aug 6, 4:00 PM

FDA approves Moderna’s m RNA flu vaccine

The Food and Drug Administration on Wednesday approved the first m RNA flu vaccine, enabling use of a technology that will make it easier to rapidly target a widely prevalent or particularl...

Open source
RightVery Low
The Gateway PunditNews report · Aug 6, 3:45 PM

FDA Reverses Course, Approves Moderna’s Experimental m RNA Flu Vaccine Months After Initial Rejection

The Food and Drug Administration (FDA) has approved Moderna’s experimental m RNA influenza vaccine, reversing an earlier decision that blocked the application over concerns about the compan...

Open source
Center-leftMostly Factual
Fast CompanyNews report · Aug 6, 3:37 PM

This new kind of flu shot by Moderna has just been approved by the FDA

The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same m RNA technology that was key to ending the COVID-19 pandemic, said th...

Open source
Show all 14 sources
CenterHigh
KING5 (Tegna, Seattle)News report · Aug 6, 3:13 PM

FDA approves first m RNA flu vaccine for adults 50+

The shot, named m Flusiva, is intended for adults age 50 or older.

Open source
CenterHigh
WUSA9 (Tegna, Washington DC)News report · Aug 6, 3:13 PM

FDA approves first m RNA flu vaccine for adults 50+

The shot, named m Flusiva, is intended for adults age 50 or older.

Open source
CenterHigh
KARE11 (Tegna, Minneapolis)News report · Aug 6, 3:13 PM

FDA approves first m RNA flu vaccine for adults 50+

The shot, named m Flusiva, is intended for adults age 50 or older.

Open source
CenterHigh
WCNC Charlotte (Tegna)News report · Aug 6, 3:13 PM

FDA approves first m RNA flu vaccine for adults 50+

The shot, named m Flusiva, is intended for adults age 50 or older.

Open source
CenterHigh
KGW8 (Tegna, Portland OR)News report · Aug 6, 3:13 PM

FDA approves first m RNA flu vaccine for adults 50+

The shot, named m Flusiva, is intended for adults age 50 or older.

Open source
CenterHigh
Global News (Canada)News report · Aug 6, 3:02 PM

FDA approves Moderna’s m RNA-based vaccine for the flu

The shot, named m Flusiva, is intended for adults age 50 or older. Moderna said late Wednesday that it expects some of its new version to be available soon at select retailers.

Open source
Details81/99 Wording Gap · High confidence · 14 sources
81/99 Wording GapHigh confidence14 sources · 3 bias bucketsStable · 14 sources · all three buckets · comparable news formatFormats: News report

SOURCE MAP CHANGES

Aug 6, 3:02 PM: Global News (Canada) joined the source map.

Aug 6, 3:13 PM: WBIR10 (Tegna, Knoxville) joined the source map.

Aug 6, 3:13 PM: WFMY News 2 (Tegna, Greensboro) joined the source map.

Aug 6, 3:13 PM: KING5 (Tegna, Seattle) joined the source map.

Now: Wording Gap is 81/99 and story health is stable · 14 sources · all three buckets · comparable news format.